Mielodiszplasztikus szindróma (MDS): vizsgálatok itt: Spanyolország
31 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 16.. Ask the study team whether a trial fits you.
- 1. fázisNot yet taking people in SpanyolországBioavailability and Bioequivalence Study of Ziftomenib in Participants With Relapsed/Refractory AML or MDS
- Where
- Barcelona, Madrid, Oviedo, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 126 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT07929740 · EU 2025-524332-19-00 - 1. fázisTaking peopleA Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
- Where
- Barcelona, Madrid, Pamplona
- People
- 225 worldwide
- Run by
- Janssen Cilag International
See details and how to join2026-525234-39-00 - 3. fázisTaking peopleA Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Salamanca, Valencia
- Életkor
- 18 év and over
- People
- 225 worldwide
- Run by
- Takeda
See details and how to joinNCT06499285 · EU 2024-516009-22-00 - 3. fázisNot yet taking people in SpanyolországA Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Salamanca, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Takeda
See details and how to joinNCT07422480 · EU 2025-523544-12-00 - 1/2. fázisTaking peopleA first time in man study to look at the safety of the experimental drug CCS1477 and what effects it has on cancers that affect the blood, bone marrow, lymph and lymphatic system.
- Where
- Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 16
- Run by
- Cellcentric Limited
See details and how to join2024-519498-20-00 - 1. fázisTaking peopleA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Barcelona, Madrid, Pamplona, Salamanca
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 1. fázisTaking peopleFirst-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Genmab
See details and how to joinNCT07384715 · EU 2025-523101-15-00 - 1. fázisTaking peopleEganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS
- Where
- Cáceres, Valencia
- Életkor
- 18 év and over
- People
- 105 worldwide
- Run by
- Stelexis BioSciences
See details and how to joinNCT06533761 · EU 2024-518071-58-00 - 2. fázisTaking peopleA Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
- Where
- Barcelona, L'Hospitalet de Llobregat, Oviedo, Salamanca, Valencia
- Életkor
- 18 év and over
- People
- 210 worldwide
- Run by
- Takeda
See details and how to joinNCT04419649 · EU 2023-507469-24-00 - 2. fázisFut, nem toborozA Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
- Where
- Barcelona, L'Hospitalet de Llobregat, Salamanca
- Életkor
- 18 év and over
- People
- 156 worldwide
- Run by
- Swedish Orphan Biovitrum
See details and how to joinNCT06782373 · EU 2024-516347-41-00 - 3. fázisTaking peopleLisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
- Where
- Badalona, Barcelona, Cáceres, Girona, L'Hospitalet de Llobregat, Madrid, Málaga, Ourense, Oviedo, Pamplona, Salamanca, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 490 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06641414 · EU 2024-517247-31-00 - 1/2. fázisTaking peopleMulti-centre Phase 1/2 study testing LB-208 for adults with relapsed/refractory AML or high-risk MDS
- Where
- Barcelona, Cáceres, Madrid, Oviedo, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 60
- Run by
- Aop Orphan Pharmaceuticals GmbH
See details and how to join2025-523396-38-00 - 2/3. fázisTaking peopleA Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Where
- Badalona, Barcelona, Cáceres, Girona, Granada, L'Hospitalet de Llobregat, Madrid, Málaga, Oviedo, Pamplona, Salamanca, Valencia
- Életkor
- 18 év and over
- People
- 316 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04256317 · EU 2024-515098-93-00 - 2. fázisNot yet taking people in SpanyolországRVU120 Rollover Study
- Where
- Pamplona
- Életkor
- 18 év and over
- People
- 14 worldwide
- Run by
- Ryvu Therapeutics SA
See details and how to joinNCT06987058 · EU 2025-521673-14-00 - 2. fázisFut, nem toboroz(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 1/2. fázisTaking peopleA Study of BGB-11417 in Participants With Myeloid Malignancies
- Where
- Barcelona, Salamanca, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 260 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT04771130 · EU 2023-508881-14-00 - 3. fázisTaking peopleIvosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
- Where
- Badalona, Barcelona, Madrid, Pamplona, Salamanca, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 48 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT06465953 · EU 2023-510155-37-00 - 2. fázisTaking peopleA Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Where
- Barcelona, Lleida, Logroño, Madrid, Murcia
- Életkor
- 18 év and over
- People
- 332 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04093570 · EU 2024-516293-29-01 - 1/2. fázisNot yet taking people in SpanyolországA Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
- Where
- Barcelona, Madrid, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Servier
See details and how to joinNCT07719348 · EU 2025-525128-88-00 - 3. fázisBefejeződöttA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Barakaldo, Barcelona, Madrid, Oviedo, Salamanca, Seville, Valencia
- Életkor
- 18 év and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060 - 1/2. fázisTaking peopleStudy to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Where
- Badalona, Barcelona, Madrid, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- CellCentric Ltd.
See details and how to joinNCT04068597 - 2. fázisTaking peopleA Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
- Where
- Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Ourense, Pamplona, Salamanca, Valencia
- Életkor
- 18 év and over
- People
- 80 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06847867 · EU 2024-519928-24-00 - 1. fázisTaking peopleStudy to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment
- Where
- Barcelona, Lleida, Logrono, Madrid, Murcia, Valencia
- Életkor
- 18 év and over
- People
- 18 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04953897 · EU 2024-516291-16-00 - 1. fázisTaking peopleStudy to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
- Where
- Barcelona, Lleida, Logrono, Madrid, Murcia, Valencia
- Életkor
- 18 év and over
- People
- 27 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04953910 · EU 2024-516292-33-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Albacete, Barcelona, Cáceres, Las Palmas, Madrid, Oviedo, Salamanca, Santander, Santiago de Compostela, Valencia
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555